Unknown

Dataset Information

0

Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation.


ABSTRACT: Constitutive androstane receptor (CAR) activation has found to ameliorate diabetes in animal models. However, no CAR agonists are available clinically. Therefore, a safe and effective CAR activator would be an alternative option. In this study, sixty courmarin derivatives either synthesized or purified from Artemisia capillaris were screened for CAR activation activity. Chemical modifications were on position 5,6,7,8 with mono-, di-, tri-, or tetra-substitutions. Among all the compounds subjected for in vitro CAR activation screening, 6,7-diprenoxycoumarin was the most effective and was selected for further preclinical studies. Chemical modification on the 6 position and unsaturated chains were generally beneficial. Electron-withdrawn groups as well as long unsaturated chains were hazardous to the activity. Mechanism of action studies showed that CAR activation of 6,7-diprenoxycoumarin might be through the inhibition of EGFR signaling and upregulating PP2Ac methylation. To sum up, modification mimicking natural occurring coumarins shed light on CAR studies and the established screening system provides a rapid method for the discovery and development of CAR activators. In addition, one CAR activator, scoparone, did showed anti-diabetes effect in db/db mice without elevation of insulin levels.

SUBMITTER: Juang SH 

PROVIDER: S-EPMC7796031 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation.

Juang Shin-Hun SH   Hsieh Min-Tsang MT   Hsu Pei-Ling PL   Chen Ju-Ling JL   Liu Hui-Kang HK   Liang Fong-Pin FP   Kuo Sheng-Chu SC   Chiu Chen-Yuan CY   Liu Shing-Hwa SH   Chou Chen-Hsi CH   Wu Tian-Shung TS   Hung Hsin-Yi HY  

Molecules (Basel, Switzerland) 20201231 1


Constitutive androstane receptor (CAR) activation has found to ameliorate diabetes in animal models. However, no CAR agonists are available clinically. Therefore, a safe and effective CAR activator would be an alternative option. In this study, sixty courmarin derivatives either synthesized or purified from <i>Artemisia capillaris</i> were screened for CAR activation activity. Chemical modifications were on position 5,6,7,8 with mono-, di-, tri-, or tetra-substitutions. Among all the compounds s  ...[more]

Similar Datasets

| S-EPMC5061317 | biostudies-literature
| S-EPMC4975621 | biostudies-literature
| S-EPMC2798732 | biostudies-literature
| S-EPMC7859440 | biostudies-literature
| S-EPMC4600658 | biostudies-literature
| S-EPMC3449269 | biostudies-literature
| S-EPMC5573139 | biostudies-literature
| S-EPMC6317430 | biostudies-literature
| S-EPMC6735724 | biostudies-literature
| S-EPMC6193428 | biostudies-literature